NCT01745887 - A Multi-Center Study Subjects With Dry Eye Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Dry Eye Syndrome

Interventions

DRUG

EBI-005-2

The investigational drug EBI-005-2, is an intervention to three different study arms. One arm gets 5mg/ml, the other gets 20mg/ml and the last arm is Placebo.

Trial Locations (8)

23502

Investigational Site, Norfolk

44115

Investigational Site, Cleveland

63090

Investigational Site, Washington

64111

Investigational Site, Kansas City

78209

Investigational Site, San Antonio

90505

Investigational Site, Torrence

90701

Investigational Site, Artesia

95670

Investigational Site, Ranchero Cordova